U.S. Food, 2026-11-21: FDA's model Drug Facts label for OTC oral benzocaine products for adults and children 2 years and older, carrying the methemoglobinemia warning, 'do not use for teething' and 'in children under 2 years of age'.
Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood.
1
U.S. Food, 2026-11-21: FDA's model Drug Facts label for OTC oral benzocaine products for adults and children 2 years and older, carrying the methemoglobinemia warning, 'do not use for teething' and 'in children under 2 years of age'. C2. Label-change document produced by the 2018 action: this is the model wording FDA asked manufacturers to adopt. Also lists the methemoglobinemia signs FDA required in the warning (pale/gray/blue skin, headache, rapid heart rate, shortness of breath, dizziness, fatigue). Quote checked against pdftotext extraction; warning text is laid out in a box on PDF page 1. document_date: access date, page undated. The link to the May 2018 action comes from the companion letter and press release (MTI-07, MTI-08). Study type: regulatory record.
